Truist Financial’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.94M Buy
+28,343
New +$2.99M ﹤0.01% 1104
2021
Q1
Sell
-3,040
Closed -$217K 2711
2020
Q4
$217K Sell
3,040
-946
-24% -$63.3K ﹤0.01% 2348
2020
Q3
$254K Buy
3,986
+668
+20% +$43.7K ﹤0.01% 2133
2020
Q2
$214K Buy
+3,318
New +$206K ﹤0.01% 2151

Other funds holding PJP

Truist Financial's PJP Position: Q1 2026 in Review

Truist Financial opened a new position in Invesco Pharmaceuticals ETF (PJP) in Q1 2026: 28,343 shares worth $2.94M. The stake represents ﹤0.01% of the portfolio and ranks #1104 among its holdings. This is a return to the name: Truist Financial previously reported a position in PJP as recently as Q4 2020.

Truist Financial first reported a position in PJP in Q2 2020 and has held it in 4 quarters since. 119 funds tracked by Wall St. Rank hold PJP as of Q1 2026.

  • Truist Financial held 28,343 shares of Invesco Pharmaceuticals ETF worth $2.94M as of Q1 2026.
  • Invesco Pharmaceuticals ETF was a new Truist Financial position in Q1 2026.
  • Invesco Pharmaceuticals ETF made up ﹤0.01% of Truist Financial's portfolio in Q1 2026, its #1104 holding.
  • Truist Financial first reported a position in Invesco Pharmaceuticals ETF in Q2 2020 and has held it in 4 quarters since.
  • 119 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q1 2026.

Based on Truist Financial's 13F filing for Q1 2026, filed 27 Apr 2026.